Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Jiangsu Bioperfectus Technologies Co Ltd
Cost of Revenue
Jiangsu Bioperfectus Technologies Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
Cost of Revenue
-¥253.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Cost of Revenue
-¥6.6B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Cost of Revenue
-¥3.6B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-12%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Cost of Revenue
-¥1.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Cost of Revenue
-¥4.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Cost of Revenue
-¥1.1B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
See Also
What is Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue?
Cost of Revenue
-253.9m
CNY
Based on the financial report for Dec 31, 2023, Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue amounts to -253.9m CNY.
What is Jiangsu Bioperfectus Technologies Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-43%
Over the last year, the Cost of Revenue growth was 89%. The average annual Cost of Revenue growth rates for Jiangsu Bioperfectus Technologies Co Ltd have been 13% over the past three years , -43% over the past five years .